3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Oropharyngeal Neoplasms
1
Mouth Neoplasms
1
Lymphoid Interstitial Pneumonia
1
Lip Neoplasms
1
Head and Neck Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
blinatumomab
5
Rituximab
4
Cyclophosphamide
4
Brentuximab Vedotin
3
ponatinib
2
Vincristine
2
Prednisone
2
Etoposide
2
Doxorubicin
2
tetulomab tetraxetan lu-177
1
pembrolizumab
1
ibrutinib
1
ibritumomab tiuxetan
1
fludarabine
1
durvalumab
1
denileukin diftitox
1
cobomarsen
1
Vorinostat
1
Melphalan
1
Lutetium
1
Lenalidomide
1
Imatinib Mesylate
1
Ifosfamide
1
Everolimus
1
Cytarabine
1
Carmustine
1
Carboplatin
1
Bendamustine Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Lymphatic Diseases
×
ficlatuzumab
×
Clear all
No trials found.